Senior Director PDM-NBE Pfizer Inc. Andover, Massachusetts
This presentation will provide an introduction to an exciting topic of Biomolecular Bioanalytical Laboratory of The Future. Together we will review challenges and opportunities facing bioanalytical scientists today and in the upcoming years. Discussion questions related to complexities of immunogenicity assays will include potential solutions for the lack of ability to compare study data between biotherapeutic compounds and growing need in a more detailed alignment of analytical methods. Similarly, bioanalysts of the future will work with a growing number of PK assays that may require cross compound comparative analysis, including biosimilar type compounds. Together we will learn and prepare for the upcoming session which is a part of the exciting AAPS PS360 2020 event.
Iintroduce discussion topics to be reviewed during session on Biomolecular Bioanalytical Laboratory of The Future.
Review challenges associated with Immunogenicity assays to be discussed during the session
Review challenges associated with PK assays to be discussed during the session